Works by Ware, Russell E.

Results: 150
    1
    2

    EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.

    Published in:
    Journal of Medical Internet Research, 2016, v. 18, n. 9, p. 18, doi. 10.2196/resprot.5872
    By:
    • Rankine-Mullings, Angela E.;
    • Little, Courtney R.;
    • Reid, Marvin E.;
    • Soares, Deanne P.;
    • Taylor-Bryan, Carolyn;
    • Knight-Madden, Jennifer M.;
    • Stuber, Susan E.;
    • Badaloo, Asha V.;
    • Aldred, Karen;
    • Wisdom-Phipps, Margaret E.;
    • Latham, Teresa;
    • Ware, Russell E.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    A pharmacokinetic study of paracetamol in Thai β-thalassemia/HbE patients.

    Published in:
    European Journal of Clinical Pharmacology, 2006, v. 62, n. 9, p. 743, doi. 10.1007/s00228-006-0167-2
    By:
    • Tankanitlert, Jeeranut;
    • Howard, Thad A.;
    • Temsakulphong, Anusorn;
    • Sirankapracha, Pornpan;
    • Morales, Noppawan;
    • Sanvarinda, Yupin;
    • Fucharoen, Pranee;
    • Ware, Russell E.;
    • Fucharoen, Suthat;
    • Chantharaksri, Udom
    Publication type:
    Article
    9
    10
    11

    Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose‐prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 9, p. E242, doi. 10.1002/ajh.25883
    By:
    • George, Alex;
    • Dinu, Bogdan;
    • Estrada, Norma;
    • Minard, Charles G.;
    • Hurwitz, Richard;
    • Mahoney, Donald H.;
    • Yates, Amber M.;
    • Vaughan, Mary;
    • Carmouche, Alaundra;
    • Airewele, Gladstone;
    • Kirk, Susan E.;
    • Fasipe, Titilope;
    • Uwaezuoke, Precious;
    • Ware, Russell E.
    Publication type:
    Article
    12
    13

    Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub‐Saharan Africa.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 4, p. 537, doi. 10.1002/ajh.25034
    By:
    • McGann, Patrick T.;
    • Williams, Thomas N.;
    • Olupot‐Olupot, Peter;
    • Tomlinson, George A.;
    • Lane, Adam;
    • Luís Reis da Fonseca, José;
    • Kitenge, Robert;
    • Mochamah, George;
    • Wabwire, Ham;
    • Stuber, Susan;
    • Howard, Thad A.;
    • McElhinney, Kathryn;
    • Aygun, Banu;
    • Latham, Teresa;
    • Santos, Brígida;
    • Tshilolo, Léon;
    • Ware, Russell E.;
    • for the REACH Investigators
    Publication type:
    Article
    14
    15
    16
    17
    18

    Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 12, p. 1099, doi. 10.1002/ajh.24198
    By:
    • Hankins, Jane S.;
    • McCarville, Mary Beth;
    • Rankine-Mullings, Angela;
    • Reid, Marvin E.;
    • Lobo, Clarisse L. C.;
    • Moura, Patricia G.;
    • Ali, Susanna;
    • Soares, Deanne P.;
    • Aldred, Karen;
    • Jay, Dennis W.;
    • Aygun, Banu;
    • Bennett, John;
    • Kang, Guolian;
    • Goldsmith, Jonathan C.;
    • Smeltzer, Matthew P.;
    • Boyett, James M.;
    • Ware, Russell E.
    Publication type:
    Article
    19
    20

    Evidence gaps in the management of sickle cell disease: A summary of needed research.

    Published in:
    2015
    By:
    • Savage, William J.;
    • Buchanan, George R.;
    • Yawn, Barbara P.;
    • Afenyi-Annan, Araba N.;
    • Ballas, Samir K.;
    • Goldsmith, Jonathan C.;
    • Hassell, Kathryn L.;
    • James, Andra H.;
    • John-Sowah, Joylene;
    • Jordan, Lanetta;
    • Lottenberg, Richard;
    • Murad, M. Hassan;
    • Ortiz, Eduardo;
    • Tanabe, Paula J.;
    • Ware, Russell E.;
    • Lanzkron, Sophie M.
    Publication type:
    Editorial
    21
    22

    Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 11, p. 932, doi. 10.1002/ajh.23547
    By:
    • Alvarez, Ofelia;
    • Yovetich, Nancy A.;
    • Scott, J. Paul;
    • Owen, William;
    • Miller, Scott T.;
    • Schultz, William;
    • Lockhart, Alexandre;
    • Aygun, Banu;
    • Flanagan, Jonathan;
    • Bonner, Melanie;
    • Mueller, Brigitta U.;
    • Ware, Russell E.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50